Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline by Seini Moimoi | Jan 7, 2021 | Portfolio News
Endeavor BioMedicines Launches With $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease by Seini Moimoi | Jan 7, 2021 | Portfolio News
LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies by Seini Moimoi | Jan 7, 2021 | Portfolio News
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections by Seini Moimoi | Jan 6, 2021 | Portfolio News
